Stock CUE CUE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-31 EDT 		5-day change 1st Jan Change
1.63 USD +2.52% Intraday chart for Cue Biopharma, Inc. +0.31% -38.26%
05-09 Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CUE BIOPHARMA, INC. Stock Cue Biopharma, Inc.
 79.29M - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. CUE Stock
  4. Charts Cue Biopharma, Inc.
  5. Sector Chart